Skip to content
Prime Therapeutics, Main logo
  • Health plans
  • Employers
  • Consultants
  • Careers
  • Resources
    • Pharmacist + Provider
    • Client + Health Plan
Member Sign In
  • About
    • Overview
    • Our History
    • Culture
    • Our Leaders
  • Who We Serve
    • Health plans
    • Employers
    • Consultants
  • News
  • Products
  • Resources
    • Pharmacy + provider
    • Client and health plan
  • Careers
    • Overview
    • Benefits
    • Open Positions
  • Contact
Member Sign In
Home/Client Communications/Competitive Intelligence report – August 2023

Competitive Intelligence report – August 2023

August 30, 2023

This monthly report covers recent events throughout our industry and provides analysis of what it could mean for Prime and our clients. This month CVS launches Cordavis for biosimilar products, there a new product launches from competitors, Rite Aid files for chapter 11 and more. Read the full report.
Prime Therapeutics Logo

Navigate

  • About
  • Products
  • News
  • Resources
  • Careers
  • Contact

Other Websites

  • Magellan Rx
  • myprime.com

Legal

  • Privacy Policy
  • Terms of Use
  • Subrogation
Prime Therapeutics Logo

Stay Connected

NCQA Certified Health Information Product
urac Accreditted Pharmacy Benefit Management Award Image with Logo
HITrust CSF Certfied
AICPA SOC for Service Organizations certification

© 2023 Prime Therapeutics LLC | Magellan Rx Management, LLC, a Prime Therapeutics LLC company